{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T12:30:32Z","timestamp":1792067432002,"version":"4.4.0"},"reference-count":48,"publisher":"American Medical Association (AMA)","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"<jats:sec><jats:title>Importance<\/jats:title><jats:p>Daytime functional impairments are the primary reasons for patients with insomnia to seek treatment, yet little is known about what the optimal treatment is for improving daytime functions and how best to proceed with treatment for patients whose insomnia has not remitted.<\/jats:p><\/jats:sec><jats:sec><jats:title>Objectives<\/jats:title><jats:p>To compare the efficacy of behavioral therapy (BT) and zolpidem as initial therapies for improving daytime functions among patients with insomnia and evaluate the added value of a second treatment for patients whose insomnia has not remitted.<\/jats:p><\/jats:sec><jats:sec><jats:title>Design, Setting, and Participants<\/jats:title><jats:p>In this sequential multiple-assignment randomized clinical trial conducted at institutions in Canada and the US, 211 adults with chronic insomnia disorder were enrolled between May 1, 2012, and December 31, 2015, and followed up for 12 months. Statistical analyses were performed on an intention-to-treat basis in April and October 2023.<\/jats:p><\/jats:sec><jats:sec><jats:title>Interventions<\/jats:title><jats:p>Participants were randomly assigned to either BT or zolpidem as first-stage therapy, and those whose insomnia had not remitted received a second-stage psychological therapy (BT or cognitive therapy) or medication therapy (zolpidem or trazodone).<\/jats:p><\/jats:sec><jats:sec><jats:title>Main Outcomes and Measures<\/jats:title><jats:p>Study outcomes were daytime symptoms of insomnia, including mood disturbances, fatigue, functional impairments of insomnia, and scores on the 36-item Short-Form Health Survey (SF-36) physical and mental health components.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Among 211 adults with insomnia (132 women [63%]; mean [SD] age, 45.6 [14.9] years), 104 were allocated to BT and 107 to zolpidem at the first stage. First-stage treatment with BT or zolpidem yielded significant and equivalent benefits for most of the daytime outcomes, including depressive symptoms (Beck Depression Inventory-II mean score change, \u22123.5 [95% CI, \u22124.7 to \u22122.3] vs \u22124.3 [95% CI, \u22125.7 to \u22122.9]), fatigue (Multidimensional Fatigue Inventory mean score change, \u22124.7 [95% CI, \u22127.3 to \u22122.2] vs \u22125.2 [95% CI, \u22127.9 to \u22122.5]), functional impairments (Work and Social Adjustment Scale mean score change, \u22125.0 [95% CI, \u22126.7 to \u22123.3] vs \u22125.1 [95% CI, \u22127.2 to \u22122.9]), and mental health (SF-36 mental health subscale mean score change, 3.5 [95% CI, 1.9-5.1] vs 2.5 [95% CI, 0.4-4.5]), while BT produced larger improvements for anxiety symptoms relative to zolpidem (State-Trait Anxiety Inventory mean score change, \u22124.1 [95% CI, \u20135.8 to \u20132.4] vs \u22121.2 [95% CI, \u22123.0 to 0.5]; <jats:italic>P<\/jats:italic>\u2009=\u2009.02; Cohen <jats:italic>d<\/jats:italic>\u2009=\u20090.55). Second-stage therapy produced additional improvements for the 2 conditions starting with zolpidem at posttreatment in fatigue (Multidimensional Fatigue Inventory mean score change: zolpidem plus BT, \u22123.8 [95% CI, \u22127.1 to \u22120.4]; zolpidem plus trazodone, \u22123.7 [95% CI, \u22126.3 to \u22121.1]), functional impairments (Work and Social Adjustment Scale mean score change: zolpidem plus BT, \u22123.7 [95% CI, \u22126.4 to \u22121.0]; zolpidem plus trazodone, \u22123.3 [95% CI, \u22125.9 to \u22120.7]) and mental health (SF-36 mental health subscale mean score change: zolpidem plus BT, 5.3 [95% CI, 2.7-7.9]; zolpidem plus trazodone, 2.0 [95% CI, 0.1-4.0]). Treatment benefits achieved at posttreatment were well maintained throughout the 12-month follow-up, and additional improvements were noted for patients receiving the BT treatment sequences.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions and Relevance<\/jats:title><jats:p>In this randomized clinical trial of adults with insomnia disorder, BT and zolpidem produced improvements for various daytime symptoms of insomnia that were no different between treatments. Adding a second treatment offered an added value with further improvements of daytime functions.<\/jats:p><\/jats:sec><jats:sec><jats:title>Trial Registration<\/jats:title><jats:p>ClinicalTrials.gov Identifier: <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/clinicaltrials.gov\/study\/NCT01651442\">NCT01651442<\/jats:ext-link><\/jats:p><\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2023.49638","type":"journal-article","created":{"date-parts":[[2023,12,28]],"date-time":"2023-12-28T16:32:13Z","timestamp":1703781133000},"page":"e2349638","source":"Crossref","is-referenced-by-count":20,"title":["Effect of Psychological and Medication Therapies for Insomnia on Daytime Functions"],"prefix":"10.1001","volume":"6","author":[{"given":"Charles M.","family":"Morin","sequence":"first","affiliation":[{"name":"Centre de Recherche CERVO\/Brain Research Center, \u00c9cole de Psychologie, Universit\u00e9 Laval, Quebec City, Quebec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Si-Jing","family":"Chen","sequence":"additional","affiliation":[{"name":"Centre de Recherche CERVO\/Brain Research Center, \u00c9cole de Psychologie, Universit\u00e9 Laval, Quebec City, Quebec, Canada"},{"name":"Li Chiu Kong Family Sleep Assessment Unit, Department of Psychiatry, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong SAR, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans","family":"Ivers","sequence":"additional","affiliation":[{"name":"Centre de Recherche CERVO\/Brain Research Center, \u00c9cole de Psychologie, Universit\u00e9 Laval, Quebec City, Quebec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Beaulieu-Bonneau","sequence":"additional","affiliation":[{"name":"Centre de Recherche CERVO\/Brain Research Center, \u00c9cole de Psychologie, Universit\u00e9 Laval, Quebec City, Quebec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew D.","family":"Krystal","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Behavioral Services, University of California, San Francisco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"Guay","sequence":"additional","affiliation":[{"name":"Centre de Recherche CERVO\/Brain Research Center, \u00c9cole de Psychologie, Universit\u00e9 Laval, Quebec City, Quebec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynda","family":"B\u00e9langer","sequence":"additional","affiliation":[{"name":"Centre de Recherche CERVO\/Brain Research Center, \u00c9cole de Psychologie, Universit\u00e9 Laval, Quebec City, Quebec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann","family":"Cartwright","sequence":"additional","affiliation":[{"name":"University of Colorado, Denver"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryan","family":"Simmons","sequence":"additional","affiliation":[{"name":"National Jewish Health, Denver, Colorado"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manon","family":"Lamy","sequence":"additional","affiliation":[{"name":"Centre de Recherche CERVO\/Brain Research Center, \u00c9cole de Psychologie, Universit\u00e9 Laval, Quebec City, Quebec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mindy","family":"Busby","sequence":"additional","affiliation":[{"name":"University of Colorado, Denver"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jack D.","family":"Edinger","sequence":"additional","affiliation":[{"name":"National Jewish Health, Denver, Colorado"},{"name":"Duke University Medical Center, Durham, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2023,12,28]]},"reference":[{"issue":"9821","key":"zoi231444r2","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1016\/S0140-6736(11)60750-2","article-title":"Chronic insomnia.","volume":"379","author":"Morin","year":"2012","journal-title":"Lancet"},{"issue":"5","key":"zoi231444r3","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1001\/archinternmed.2008.610","article-title":"The natural history of insomnia: a population-based 3-year longitudinal study.","volume":"169","author":"Morin","year":"2009","journal-title":"Arch Intern Med"},{"issue":"11","key":"zoi231444r4","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.18782","article-title":"Incidence, persistence, and remission rates of insomnia over 5 years.","volume":"3","author":"Morin","year":"2020","journal-title":"JAMA Netw Open"},{"issue":"3","key":"zoi231444r5","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.amjmed.2014.10.015","article-title":"Persistent insomnia is associated with mortality risk.","volume":"128","author":"Parthasarathy","year":"2015","journal-title":"Am J Med"},{"issue":"1","key":"zoi231444r6","first-page":"55","article-title":"The economic burden of insomnia: direct and indirect costs for individuals with insomnia syndrome, insomnia symptoms, and good sleepers.","volume":"32","author":"Daley","year":"2009","journal-title":"Sleep"},{"issue":"8","key":"zoi231444r7","first-page":"617","article-title":"Insomnia risks and costs: health, safety, and quality of life.","volume":"16","author":"Rosekind","year":"2010","journal-title":"Am J Manag Care"},{"issue":"5","key":"zoi231444r8","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1093\/sleep\/25.5.548","article-title":"Symptom reports in severe chronic insomnia.","volume":"25","author":"Moul","year":"2002","journal-title":"Sleep"},{"issue":"3","key":"zoi231444r9","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1080\/15402002.2010.487450","article-title":"\u201c...Not just a minor thing, it is something major, which stops you from functioning daily\u201d: quality of life and daytime functioning in insomnia.","volume":"8","author":"Kyle","year":"2010","journal-title":"Behav Sleep Med"},{"issue":"1","key":"zoi231444r10","doi-asserted-by":"publisher","first-page":"107","DOI":"10.5665\/sleep.3318","article-title":"Neurobehavioral performance impairment in insomnia: relationships with self-reported sleep and daytime functioning.","volume":"37","author":"Shekleton","year":"2014","journal-title":"Sleep"},{"issue":"2","key":"zoi231444r11","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.sleep.2005.08.008","article-title":"Epidemiology of insomnia: prevalence, self-help treatments, consultations, and determinants of help-seeking behaviors.","volume":"7","author":"Morin","year":"2006","journal-title":"Sleep Med"},{"issue":"4","key":"zoi231444r12","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/S0033-3182(89)72248-9","article-title":"Characteristics of individuals who do or do not seek treatment for chronic insomnia.","volume":"30","author":"Stepanski","year":"1989","journal-title":"Psychosomatics"},{"issue":"2","key":"zoi231444r13","doi-asserted-by":"publisher","first-page":"307","DOI":"10.5664\/jcsm.6470","article-title":"Clinical practice guideline for the pharmacologic treatment of chronic insomnia in adults: an American Academy of Sleep Medicine Clinical Practice Guideline.","volume":"13","author":"Sateia","year":"2017","journal-title":"J Clin Sleep Med"},{"issue":"6","key":"zoi231444r14","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1111\/jsr.2017.26.issue-6","article-title":"European guideline for the diagnosis and treatment of insomnia.","volume":"26","author":"Riemann","year":"2017","journal-title":"J Sleep Res"},{"issue":"2","key":"zoi231444r15","doi-asserted-by":"publisher","first-page":"103","DOI":"10.7326\/M15-1781","article-title":"Pharmacologic treatment of insomnia disorder: an evidence report for a clinical practice guideline by the American College of Physicians.","volume":"165","author":"Wilt","year":"2016","journal-title":"Ann Intern Med"},{"key":"zoi231444r16","doi-asserted-by":"publisher","DOI":"10.1016\/j.cpr.2020.101873","article-title":"The efficacy of cognitive and behavior therapies for insomnia on daytime symptoms: a systematic review and network meta-analysis.","volume":"80","author":"Benz","year":"2020","journal-title":"Clin Psychol Rev"},{"issue":"3","key":"zoi231444r17","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1007\/s10567-017-0234-5","article-title":"Systematic review and meta-analysis of adolescent cognitive-behavioral sleep interventions.","volume":"20","author":"Blake","year":"2017","journal-title":"Clin Child Fam Psychol Rev"},{"issue":"4","key":"zoi231444r18","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1093\/sleep\/31.4.489","article-title":"Cognitive behavioral therapy for insomnia enhances depression outcome in patients with comorbid major depressive disorder and insomnia.","volume":"31","author":"Manber","year":"2008","journal-title":"Sleep"},{"issue":"2","key":"zoi231444r19","doi-asserted-by":"publisher","first-page":"267","DOI":"10.5665\/sleep.4412","article-title":"Internet treatment addressing either insomnia or depression, for patients with both diagnoses: a randomized trial.","volume":"38","author":"Blom","year":"2015","journal-title":"Sleep"},{"issue":"17","key":"zoi231444r20","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.1001\/archinte.164.17.1888","article-title":"Cognitive behavior therapy and pharmacotherapy for insomnia: a randomized controlled trial and direct comparison.","volume":"164","author":"Jacobs","year":"2004","journal-title":"Arch Intern Med"},{"issue":"5","key":"zoi231444r21","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1016\/j.brat.2008.02.013","article-title":"Daytime functioning in older patients suffering from chronic insomnia: treatment outcome in a randomized controlled trial comparing CBT with zopiclone.","volume":"46","author":"Omvik","year":"2008","journal-title":"Behav Res Ther"},{"issue":"12","key":"zoi231444r22","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1016\/j.brat.2004.11.011","article-title":"Sequential combinations of drug and cognitive behavioral therapy for chronic insomnia: an exploratory study.","volume":"43","author":"Valli\u00e8res","year":"2005","journal-title":"Behav Res Ther"},{"issue":"6","key":"zoi231444r23","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1017\/S1092852900029266","article-title":"Insomnia in patients with depression: a STAR*D report.","volume":"15","author":"Sunderajan","year":"2010","journal-title":"CNS Spectr"},{"issue":"1","key":"zoi231444r24","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1186\/s13063-016-1242-3","article-title":"Sequential psychological and pharmacological therapies for comorbid and primary insomnia: study protocol for a randomized controlled trial.","volume":"17","author":"Morin","year":"2016","journal-title":"Trials"},{"issue":"11","key":"zoi231444r25","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1001\/jamapsychiatry.2020.1767","article-title":"Effectiveness of sequential psychological and medication therapies for insomnia disorder: a randomized clinical trial.","volume":"77","author":"Morin","year":"2020","journal-title":"JAMA Psychiatry"},{"issue":"1","key":"zoi231444r26","doi-asserted-by":"publisher","DOI":"10.1093\/sleep\/zsab245","article-title":"Association between insomnia patients\u2019 pre-treatment characteristics and their responses to distinctive treatment sequences.","volume":"45","author":"Edinger","year":"2022","journal-title":"Sleep"},{"issue":"19","key":"zoi231444r27","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.1001\/jama.2009.682","article-title":"Cognitive behavioral therapy, singly and combined with medication, for persistent insomnia: a randomized controlled trial.","volume":"301","author":"Morin","year":"2009","journal-title":"JAMA"},{"issue":"5","key":"zoi231444r28","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.17m12020","article-title":"Insomnia and impaired quality of life in the United States.","volume":"79","author":"Olfson","year":"2018","journal-title":"J Clin Psychiatry"},{"issue":"6","key":"zoi231444r29","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1097\/00005650-199206000-00002","article-title":"The MOS 36-item short-form health survey (SF-36), I: conceptual framework and item selection.","volume":"30","author":"Ware","year":"1992","journal-title":"Med Care"},{"issue":"3","key":"zoi231444r32","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/0022-3999(94)00125-O","article-title":"The Multidimensional Fatigue Inventory (MFI) psychometric qualities of an instrument to assess fatigue.","volume":"39","author":"Smets","year":"1995","journal-title":"J Psychosom Res"},{"key":"zoi231444r33","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1192\/bjp.180.5.461","article-title":"The Work and Social Adjustment Scale: a simple measure of impairment in functioning.","volume":"180","author":"Mundt","year":"2002","journal-title":"Br J Psychiatry"},{"issue":"1","key":"zoi231444r34","first-page":"45","article-title":"Treatment of chronic insomnia by restriction of time in bed.","volume":"10","author":"Spielman","year":"1987","journal-title":"Sleep"},{"issue":"5","key":"zoi231444r36","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1111\/j.1467-8721.2008.00594.x","article-title":"Insomnia, psychiatric disorders, and the transdiagnostic perspective.","volume":"17","author":"Harvey","year":"2008","journal-title":"Curr Dir Psychol Sci"},{"issue":"12","key":"zoi231444r37","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1007\/s40263-012-0010-5","article-title":"Rediscovering trazodone for the treatment of major depressive disorder.","volume":"26","author":"Fagiolini","year":"2012","journal-title":"CNS Drugs"},{"key":"zoi231444r38","author":"Jaffer","year":"2017","journal-title":"Innov Clin Neurosci"},{"issue":"4","key":"zoi231444r39","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1037\/a0029372","article-title":"Experimental design and primary data analysis methods for comparing adaptive interventions.","volume":"17","author":"Nahum-Shani","year":"2012","journal-title":"Psychol Methods"},{"issue":"2","key":"zoi231444r40","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1177\/1094428104263672","article-title":"Using generalized estimating equations for longitudinal data analysis.","volume":"7","author":"Ballinger","year":"2004","journal-title":"ORM"},{"issue":"9","key":"zoi231444r43","doi-asserted-by":"publisher","first-page":"3089","DOI":"10.3390\/jcm12093089","article-title":"Do insomnia treatments improve daytime function?","volume":"12","author":"Watson","year":"2023","journal-title":"J Clin Med"},{"issue":"8","key":"zoi231444r44","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1016\/j.sleep.2011.03.016","article-title":"No pain, no gain: an exploratory within-subjects mixed-methods evaluation of the patient experience of sleep restriction therapy (SRT) for insomnia.","volume":"12","author":"Kyle","year":"2011","journal-title":"Sleep Med"},{"issue":"1","key":"zoi231444r45","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/S0893-133X(00)00249-9","article-title":"Response in relation to baseline anxiety levels in major depressive disorder treated with bupropion sustained release or sertraline.","volume":"25","author":"Rush","year":"2001","journal-title":"Neuropsychopharmacology"},{"issue":"10","key":"zoi231444r46","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1017\/S1092852900025815","article-title":"Defining response and remission in anxiety disorders: toward an integrated approach.","volume":"11","author":"Bandelow","year":"2006","journal-title":"CNS Spectr"},{"key":"zoi231444r47","doi-asserted-by":"publisher","DOI":"10.1016\/j.smrv.2020.101378","article-title":"Does cognitive behaviour therapy for insomnia reduce repetitive negative thinking and sleep-related worry beliefs? a systematic review and meta-analysis.","volume":"55","author":"Ballesio","year":"2021","journal-title":"Sleep Med Rev"},{"issue":"8","key":"zoi231444r48","doi-asserted-by":"publisher","DOI":"10.1093\/sleep\/zsz122","article-title":"Residual symptoms after natural remission of insomnia: associations with relapse over 4 years.","volume":"42","author":"Ji","year":"2019","journal-title":"Sleep"},{"key":"zoi231444r1","doi-asserted-by":"crossref","DOI":"10.1176\/appi.books.9780890425596","volume-title":"Diagnostic and Statistical Manual of Mental Disorders","author":"American Psychiatric Association","year":"2013","edition":"5th ed"},{"key":"zoi231444r30","volume-title":"Manual for the Beck Depression Inventory-II","author":"Beck","year":"1996"},{"key":"zoi231444r31","volume-title":"Manual for the State-Trait Anxiety Inventory (STAI)","author":"Spielberger","year":"1983"},{"key":"zoi231444r35","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/978-1-4757-9586-8_2","volume-title":"Case Studies in Insomnia","author":"Bootzin","year":"1991"},{"key":"zoi231444r41","volume-title":"Guideline on Adjustment for Baseline Covariates in Clinical Trials (No. EMA\/CHMP\/295050\/2013)","author":"European Medicines Agency","year":"2015"},{"key":"zoi231444r42","doi-asserted-by":"crossref","DOI":"10.4135\/9781483384733","volume-title":"Experimental Design: Procedures for the Behavioral Sciences","author":"Kirk","year":"2013","edition":"4th ed"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2813414\/morin_2023_oi_231444_1702931699.87349.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,28]],"date-time":"2023-12-28T16:32:22Z","timestamp":1703781142000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2813414"}},"subtitle":["A Randomized Clinical Trial"],"short-title":[],"issued":{"date-parts":[[2023,12,28]]},"references-count":48,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2023,12,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2023.49638","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,28]]}}}